Parkinson's disease

Results show it is possible to identify Parkinson's based on compounds on the skin

Powerful AI machine learning technology could provide early detection of Parkinson's disease based on retina vasculature

Some patients diagnosed with Parkinson's disease may actually have rare genetic brain disorder

Recent research results set a foundation for future studies to investigate the potential of this biomarker to accelerate the diagnosis of neurodegenerative diseases

An international team of scientists has clarified the cause for certain genetic forms of Parkinson's disease, and has identified potential pharmacological treatments

The findings pave the way for new regenerative treatments for these diseases

Cellectricon offers fully validated in vitro disease models including human iPSC-derived neuronal cultures, cell lines, and native neuronal cultures

Researchers have mapped out the cell types behind various brain disorders, finding that cells from the gut's nervous system are involved in Parkinson's disease 

Cyclical amplification could allow doctors a 'look into the future' to pursue correct treatment